Jyoti Malhotra

14PUBLICATIONS
82CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Feb 22, 2026
Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients with Select Solid Tumors.

Jong Chul Park, David Berz, Manish R Sharma

|Jan 27, 2026
Phase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients With Select Solid Tumors.

Jong Chul Park, David Berz, Manish R Sharma

|Nov 27, 2025
Current Clinical Paradigm and Therapeutic Advancements in Thymic Malignancies: A Narrative Review.

Douglas Dias E Silva, Beatriz Viesser Miyamura, Isa Mambetsariev

|Aug 04, 2025
Treating EGFR-mutant nonsmall cell lung cancer is no longer a one-size-fits-all approach.

Lauren J Antrim, Jyoti Malhotra

Pageof 3